Charles Silberstein

Insider Reports History

Entity
Individual
Location
C/O Applied Therapeutics, Inc., 545 5 Th Avenue Suite 1400, New York, NY
Signature
/s/ Shoshana Shendelman as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles Silberstein:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Applied Therapeutics Inc. Chief Financial Officer Common Stock 184K $400K $2.18 Jan 7, 2022 Direct
Applied Therapeutics Inc. Chief Financial Officer Employee Stock Option (Right to Buy) 32K Jan 7, 2022 Direct

Insider Reports Filed by Charles Silberstein

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APLT Applied Therapeutics Inc. Jan 7, 2022 2 $0 4 Jan 11, 2022 Chief Financial Officer
APLT Applied Therapeutics Inc. Dec 14, 2021 1 $0 4/A Jan 11, 2022 Chief Financial Officer
APLT Applied Therapeutics Inc. Jun 8, 2021 1 -$108K 4 Jun 10, 2021 Chief Financial Officer